Not sure if they are on track. These were the goals for Q1 of 2022 released in updated Presentation on 3/2/22:
- EXO-NET collaborations (AU)
- Feasibility results for SubB2M immunoassay for breast cancer
- Manufacturing agreement for SubB2M
- SubB2M publication (breast cancer)
Still a couple of days left in Q1 2022, but haven't heard of progress on any of the goals for the quarter? Hopefully we'll hear soon but not looking promising.
Not sure if they are on track. These were the goals for Q1 of...
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
-0.020(3.45%) |
Mkt cap ! $62.03M | |||
| Open | High | Low | Value | Volume |
| 58.0¢ | 59.0¢ | 56.0¢ | $22.11K | 38.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 55.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.0¢ | 8625 | 1 |
View Market Depth
| Last trade - 15.49pm 30/08/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |